Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics
Conclusion:
Children and adolescents who are CYP2D6 PMs/IMs may have an increased risk for risperidone AEs. Of the genes and variants studied, only CYP2D6 has consistent association and sufficient data for clinical use, whereas HTR2A-rs6311 has limited data and requires further study.
Source: Journal of Developmental and Behavioral Pediatrics - Category: Child Development Tags: Original Article Source Type: research
More News: Child Development | Children | Genetics | Pediatrics | Risperdal Consta | Statistics | Study